Osaic Holdings
ONC

Osaic Holdings’s BeOne Medicines Ltd ONC Stock Holding History

Osaic Holdings’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Buy
1,162
+847
+269% +$250K ﹤0.01% 4010
2026
Q1 		$93.5K Buy
315
+18
+6% +$5.83K ﹤0.01% 4739
2025
Q4 		$90.2K Sell
297
-1,468
-83% -$481K ﹤0.01% 4797
2025
Q3 		$594K Sell
1,765
-1,346
-43% -$409K ﹤0.01% 3296
2025
Q2 		$774K Buy
3,111
+2,730
+717% +$670K ﹤0.01% 2733
2025
Q1 		$104K Sell
381
-383
-50% -$89.5K ﹤0.01% 4137
2024
Q4 		$141K Sell
764
-174
-19% -$35.6K ﹤0.01% 3911
2024
Q3 		$211K Sell
938
-138
-13% -$24.8K ﹤0.01% 3604
2024
Q2 		$154K Buy
1,076
+382
+55% +$58.9K ﹤0.01% 3781
2024
Q1 		$109K Sell
694
-1,202
-63% -$194K ﹤0.01% 4185
2023
Q4 		$342K Sell
1,896
-323
-15% -$58.4K ﹤0.01% 3485
2023
Q3 		$399K Buy
2,219
+515
+30% +$102K ﹤0.01% 3444
2023
Q2 		$305K Buy
1,704
+41
+2% +$9.44K ﹤0.01% 3570
2023
Q1 		$360K Sell
1,663
-194
-10% -$46.5K ﹤0.01% 3389
2022
Q4 		$408K Buy
1,857
+364
+24% +$66.8K ﹤0.01% 3210
2022
Q3 		$201K Buy
1,493
+43
+3% +$7.38K ﹤0.01% 3736
2022
Q2 		$235K Buy
1,450
+143
+11% +$22.3K ﹤0.01% 3639
2022
Q1 		$317K Sell
1,307
-22
-2% -$4.68K ﹤0.01% 3639
2021
Q4 		$360K Buy
1,329
+272
+26% +$91.8K ﹤0.01% 3388
2021
Q3 		$383K Sell
1,057
-112
-10% -$36.6K ﹤0.01% 3309
2021
Q2 		$401K Buy
1,169
+276
+31% +$91.4K ﹤0.01% 3246
2021
Q1 		$310K Buy
893
+171
+24% +$56.6K ﹤0.01% 3345
2020
Q4 		$186K Sell
722
-25
-3% -$6.88K ﹤0.01% 3553
2020
Q3 		$213K Buy
747
+165
+28% +$38.8K ﹤0.01% 3191
2020
Q2 		$110K Sell
582
-3
-0.5% -$488 ﹤0.01% 3623
2020
Q1 		$72K Buy
+585
New +$91.5K ﹤0.01% 3720

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Osaic Holdings's ONC Position: Q2 2026 in Review

Osaic Holdings increased its BeOne Medicines Ltd (ONC) stake by 269% in Q2 2026, buying an estimated $250K and bringing the position to 1,162 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #4010.

Osaic Holdings first reported a position in ONC in Q1 2020 and has held it in 26 quarters since. The position peaked at $774K in Q2 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Osaic Holdings held 1,162 shares of BeOne Medicines Ltd worth $331K as of Q2 2026.
  • Osaic Holdings bought 847 BeOne Medicines Ltd shares in Q2 2026, an estimated $250K.
  • BeOne Medicines Ltd made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4010 holding.
  • Osaic Holdings first reported a position in BeOne Medicines Ltd in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's BeOne Medicines Ltd position peaked at $774K in Q2 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.